Home » Topics » Conferences

Conferences
RSS

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

Pharmacokinetic data for pentafuside in rodents, monkeys and man

April 29, 1997

RPR describes novel farnesyltransferase inhibitors

April 28, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...